Stamford, CT -- (SBWIRE) -- 10/24/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: FREDDIE MAC PFD Z (OTCBB:FMCKJ), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Venaxis Inc (NASDAQ:APPY), Standard Pacific Corp. (NYSE:SPF)
FREDDIE MAC PFD Z (OTCBB:FMCKJ) ended higher +8.02% and complete the day at $6.60. The total number of shares changed hands during the day was 1.79 million. After opening at $6.08, the stock hit as high as $6.70. However, it traded between $1.36 and $7.24 over the last twelve months. Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States.
For How Long FMCKJ will Fight for Profitability? Read This Trend Analysis report
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) closed yesterday at $4.03, a -18.36% decrease. Around 3.82 million shares were traded, beating an-average trading volume of 1.12 million shares. The company is now valued at around $336.18 million. ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the discovery and development of new cancer therapies. The company is employing novel gene expression and control technology to deliver DNA for the treatment of cancer.
Has ZIOP Found The Bottom And Ready To Gain Momentum? Find Out Here
Venaxis Inc (NASDAQ:APPY) moved -6.12 percent lower at $1.84 and traded between $1.78 and $1.97 after opening the day at $1.84. Its performance over the last five days remained -1.6%. Going back further than one month, 1-year performance after recent close was -28.12%. Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. The company?s research and development activities primarily focus on a human acute appendicitis blood-based test.
Why Should Investors Buy APPY After the Recent Fall? Just Go Here and Find Out
Standard Pacific Corp. (NYSE:SPF)’s shares rose, +2.54 percent to close at $8.08. The stock is up around +9.93% this year and +4.94% for the last 12 months. Around 7.41 million shares changed hands yesterday, higher from an-average trading volume of 4.19 million shares. Standard Pacific Corp. operates as a builder of single-family attached and detached homes in the United States. It constructs homes targeting various homebuyers primarily move-up buyers in metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado.
Why Should Investors Buy SPF After The Recent Gain? Just Go Here and Find Out
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)